Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
AI has a lot of promise in the healthcare industry in areas such as documentation, imaging, and quicker diagnostics as staffing shortages loom.
The Gym Group announced on Wednesday that in the first six months of this year it swung back to a profit for the first time since 2019.
With rising valuations, sports team ownership should be a slam dunk. But it’s also possible those valuations are a little rich.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Shares in major video game publisher Ubisoft took an over 7% hit on Monday after a minor investor’s letter.
On Monday, the Murdoch family was once again asked the $15 billion question: Who will take over the company after Rupert is no longer around?
While this could create a lucrative new revenue stream for Ford, it also presents a privacy conundrum, one expert said.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
American Transit Insurance Company (ATIC) insures over 60% of 117,000 taxis and for-hire vehicles. And it’s insolvent.
Some fans found that while they were waiting to buy Oasis tickets, the prices had quietly crept up from £135 ($177) to £350 ($460).
Days after Brent crude oil prices fell under $74 per barrel, the member nations of OPEC+ agreed to delay a production increase for two months.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.